NO20053125D0 - Rekombinant koppevirus omfattende i det minste to kukoppe-ati-promotere. - Google Patents
Rekombinant koppevirus omfattende i det minste to kukoppe-ati-promotere.Info
- Publication number
- NO20053125D0 NO20053125D0 NO20053125A NO20053125A NO20053125D0 NO 20053125 D0 NO20053125 D0 NO 20053125D0 NO 20053125 A NO20053125 A NO 20053125A NO 20053125 A NO20053125 A NO 20053125A NO 20053125 D0 NO20053125 D0 NO 20053125D0
- Authority
- NO
- Norway
- Prior art keywords
- smallpox
- recombinant
- seq
- ati
- virus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C12N15/863—Poxviral vectors, e.g. entomopoxvirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/60—Vector systems having a special element relevant for transcription from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- AIDS & HIV (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200201814 | 2002-11-25 | ||
PCT/EP2003/012610 WO2004048582A2 (en) | 2002-11-25 | 2003-11-12 | Recombinant poxvirus comprising at least two cowpox ati promoters |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20053125L NO20053125L (no) | 2005-06-24 |
NO20053125D0 true NO20053125D0 (no) | 2005-06-24 |
Family
ID=32337938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20053125A NO20053125D0 (no) | 2002-11-25 | 2005-06-24 | Rekombinant koppevirus omfattende i det minste to kukoppe-ati-promotere. |
Country Status (21)
Country | Link |
---|---|
US (1) | US7300658B2 (no) |
EP (1) | EP1567653B1 (no) |
JP (1) | JP2006515170A (no) |
KR (1) | KR20050083839A (no) |
CN (1) | CN1717488A (no) |
AT (1) | ATE365220T1 (no) |
AU (1) | AU2003293675B2 (no) |
CA (1) | CA2501168A1 (no) |
CY (1) | CY1106883T1 (no) |
DE (1) | DE60314541T2 (no) |
DK (1) | DK1567653T3 (no) |
EA (1) | EA012723B1 (no) |
ES (1) | ES2288634T3 (no) |
IL (1) | IL167844A (no) |
MX (1) | MXPA05005549A (no) |
NO (1) | NO20053125D0 (no) |
NZ (1) | NZ540156A (no) |
PL (1) | PL375740A1 (no) |
PT (1) | PT1567653E (no) |
UA (1) | UA85379C2 (no) |
WO (1) | WO2004048582A2 (no) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ524661A (en) * | 2000-11-23 | 2005-03-24 | Bavarian Nordic As | Modified vaccinia ankara virus variant |
US7501127B2 (en) | 2002-05-16 | 2009-03-10 | Bavarian Nordic A/S | Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of Modified Vaccinia virus Ankara |
EA007811B1 (ru) * | 2002-05-16 | 2007-02-27 | Бавариан Нордик А/С | Межгенные области, используемые в качестве инсерционных сайтов в геноме модифицированного вируса коровьей оспы анкара (mva) |
EP2426142A3 (en) | 2006-10-16 | 2012-06-13 | Genelux Corporation | Modified vaccinia virus strains for use in a diagnostic and therapeutic method |
US20110052627A1 (en) * | 2008-06-20 | 2011-03-03 | Paul Chaplin | Recombinant modified vaccinia virus measles vaccine |
JP2012509073A (ja) | 2008-11-21 | 2012-04-19 | バヴァリアン・ノルディック・アクティーゼルスカブ | 複数の相同ヌクレオチド配列を含むベクター |
US8394385B2 (en) * | 2009-03-13 | 2013-03-12 | Bavarian Nordic A/S | Optimized early-late promoter combined with repeated vaccination favors cytotoxic T cell response against recombinant antigen in MVA vaccines |
WO2013115884A2 (en) * | 2011-11-15 | 2013-08-08 | Trustees Of Boston University | Pyridopyrimidinone inhibitors of viruses |
WO2016115116A1 (en) | 2015-01-12 | 2016-07-21 | Geovax, Inc. | Compositions and methods for generating an immune response to a hemorrhagic fever virus |
KR20160140075A (ko) | 2015-05-29 | 2016-12-07 | 코오롱생명과학 주식회사 | 폭스바이러스 유래 프로모터 및 이를 포함하는 벡터 |
FR3042121A1 (fr) | 2015-10-08 | 2017-04-14 | Jean-Marc Limacher | Composition anti-tumorale |
BR112018010639A2 (pt) * | 2015-11-24 | 2019-01-22 | Glaxosmithkline Ip Dev Ltd | método de transfecção transitória para produção retroviral. |
EP3380604B1 (en) * | 2015-11-24 | 2022-12-28 | GlaxoSmithKline Intellectual Property Development Limited | Stable cell lines for retroviral production |
EP3402802B1 (en) | 2016-01-08 | 2023-04-12 | Geovax, Inc. | Compositions and methods for generating an immune response to a tumor associated antigen |
BR112018015696A2 (pt) | 2016-02-03 | 2018-12-26 | Geovax Inc | composições e métodos para gerar uma resposta imune para um flavivírus |
KR20230113832A (ko) * | 2016-08-09 | 2023-08-01 | 시티 오브 호프 | 키메라 폭스바이러스 조성물 및 이의 용도 |
US11311612B2 (en) | 2017-09-19 | 2022-04-26 | Geovax, Inc. | Compositions and methods for generating an immune response to treat or prevent malaria |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5443964A (en) * | 1987-08-10 | 1995-08-22 | Duke University | Poxvirus insertion/expression vector |
US5759841A (en) * | 1990-11-20 | 1998-06-02 | Virogenetics Corporation | Immunological composition of measles virus utilizing recombinant poxvirus |
UA68327C2 (en) * | 1995-07-04 | 2004-08-16 | Gsf Forschungszentrum Fur Unwe | A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals |
AU4556597A (en) * | 1996-09-24 | 1998-04-17 | Bavarian Nordic Research Institute A/S | Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines |
US6682742B1 (en) * | 1999-05-28 | 2004-01-27 | Gsf Forschungszentrum Fur Unwelt Und Gesundheit Gmbh | Vector for integration of heterologous sequences into poxviral genomes |
US7034141B2 (en) | 2000-08-29 | 2006-04-25 | Wyeth Holdings Corporation | Packaging of positive-strand RNA virus replicon particles |
-
2003
- 2003-11-12 PT PT03789029T patent/PT1567653E/pt unknown
- 2003-11-12 CN CNA2003801040985A patent/CN1717488A/zh active Pending
- 2003-11-12 US US10/535,371 patent/US7300658B2/en not_active Expired - Fee Related
- 2003-11-12 PL PL03375740A patent/PL375740A1/xx not_active Application Discontinuation
- 2003-11-12 UA UAA200506292A patent/UA85379C2/ru unknown
- 2003-11-12 MX MXPA05005549A patent/MXPA05005549A/es active IP Right Grant
- 2003-11-12 AU AU2003293675A patent/AU2003293675B2/en not_active Ceased
- 2003-11-12 WO PCT/EP2003/012610 patent/WO2004048582A2/en active IP Right Grant
- 2003-11-12 EA EA200500879A patent/EA012723B1/ru not_active IP Right Cessation
- 2003-11-12 AT AT03789029T patent/ATE365220T1/de active
- 2003-11-12 DK DK03789029T patent/DK1567653T3/da active
- 2003-11-12 JP JP2004554335A patent/JP2006515170A/ja active Pending
- 2003-11-12 CA CA002501168A patent/CA2501168A1/en not_active Abandoned
- 2003-11-12 DE DE60314541T patent/DE60314541T2/de not_active Expired - Lifetime
- 2003-11-12 EP EP03789029A patent/EP1567653B1/en not_active Expired - Lifetime
- 2003-11-12 ES ES03789029T patent/ES2288634T3/es not_active Expired - Lifetime
- 2003-11-12 NZ NZ540156A patent/NZ540156A/en not_active IP Right Cessation
- 2003-11-12 KR KR1020057007295A patent/KR20050083839A/ko active IP Right Grant
-
2005
- 2005-04-04 IL IL167844A patent/IL167844A/en not_active IP Right Cessation
- 2005-06-24 NO NO20053125A patent/NO20053125D0/no not_active Application Discontinuation
-
2007
- 2007-09-20 CY CY20071101220T patent/CY1106883T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
UA85379C2 (ru) | 2009-01-26 |
JP2006515170A (ja) | 2006-05-25 |
CN1717488A (zh) | 2006-01-04 |
PT1567653E (pt) | 2007-10-01 |
CY1106883T1 (el) | 2012-09-26 |
EP1567653B1 (en) | 2007-06-20 |
EA200500879A1 (ru) | 2005-10-27 |
NO20053125L (no) | 2005-06-24 |
AU2003293675B2 (en) | 2009-04-23 |
DK1567653T3 (da) | 2007-10-15 |
EP1567653A2 (en) | 2005-08-31 |
EA012723B1 (ru) | 2009-12-30 |
DE60314541D1 (de) | 2007-08-02 |
PL375740A1 (en) | 2005-12-12 |
KR20050083839A (ko) | 2005-08-26 |
US7300658B2 (en) | 2007-11-27 |
WO2004048582A3 (en) | 2004-08-12 |
AU2003293675A1 (en) | 2004-06-18 |
NZ540156A (en) | 2006-11-30 |
ATE365220T1 (de) | 2007-07-15 |
IL167844A (en) | 2011-03-31 |
ES2288634T3 (es) | 2008-01-16 |
WO2004048582A2 (en) | 2004-06-10 |
CA2501168A1 (en) | 2004-06-10 |
DE60314541T2 (de) | 2008-02-28 |
MXPA05005549A (es) | 2005-08-16 |
US20060153874A1 (en) | 2006-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20053125D0 (no) | Rekombinant koppevirus omfattende i det minste to kukoppe-ati-promotere. | |
HK1076835A1 (en) | Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter | |
UA82998C2 (ru) | Экспрессия генов в модифицированном вирусе коровьей оспы ankara с использованием коровьего поксвирусного промотора аті | |
IL204539A (en) | Foxvirus virus containing defective genes and a losing gene | |
US6869793B2 (en) | Recombinant MVA virus expressing dengue virus antigens, and the use thereof in vaccines | |
WO2001089559A3 (en) | Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine | |
JP5952112B2 (ja) | ポックスウイルスまたは他の感染性因子に対する免疫の急速な誘導に改変ポックスウイルスを使用する方法 | |
CN101142319B (zh) | 基于使用修饰安卡拉痘苗病毒的疫苗 | |
WO2003023040A3 (en) | Vaccinia virus mva-e3l-knockout-mutants and use thereof | |
KR20180058705A (ko) | 재조합 orf 바이러스 벡터 | |
UA84667C2 (ru) | Вакцина, направленная против инфекции, вызванной вирусом герпеса болезни марека | |
CA2372709A1 (en) | Vector for integration of heterologous sequences into poxviral genomes | |
DK1356062T3 (da) | Frembringelse af rekombinanter af kunstigt gærkromosom af human cytomegalovirus | |
CA2430115A1 (en) | Recombinant rsv virus expression systems and vaccines | |
JP2009232836A5 (no) | ||
NZ512341A (en) | Polynucleotides between 15 and 100 base pairs in length coding for parapoxvirus ovis (PPVO)/vaccinia virus recombinant (VVOV) viral genome fragments | |
BR0316553A (pt) | Poxvìrus recombinante que compreende pelo menos dois promotores ati de varìola bovina | |
DK200201813A (da) | Ekspression af gener i modificeret vaccinia virus ankara ved brug af ATI promotoren fra ko-kopper | |
Cheng et al. | 106 Gln Glu Glu 122 Met Met Val |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |